Assessment of palmar subcutaneous tissue vascularization in patients with Dupuytren’s contracture

doi:10.5312/wjo.v9.i9.130

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13923)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

551

WORD

301

HTML

10609

Figures (1-3)

351

Tables (1-4)

306

Sum=12118

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

708

Download

1097

Sum=1805

Sep 18, 2018 (publication date) through Feb 15, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Orthopedics

ISSN

2218-5836

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Orthop. Sep 18, 2018; 9(9): 130-137
Published online Sep 18, 2018. doi: 10.5312/wjo.v9.i9.130

Table 1 Characteristics of Dupuytren’s contracture patients (n = 87) n (%)

Parameter	Value
Demographic characteristics
Age (M ± σ) (min-maх)	(59 ± 10) (24-83)
Male:Female relation	8:01
Status localis
Frequency of bilateral affection	28 (32, 18)
Duration of disease, years – (min-max) - Me (Q1; Q3)	(0.5-20) - 5 (4; 10)
Level of contracture – (min-max) - Me (Q1; Q3)	(2-4) - 2.5 (2; 3)
Number of fingers with impaired function (Min-max) - Me (Q1; Q3)	(1-8) - 2 (1-2)
Comorbid conditions
Arterial hypertension	41 (47.1)
Ischemic heart disease	5 (5.7)
Chronic cardial insufficiency	3 (3.4)
Postinfarction cardiosclerosis	2 (2.3)
Diabetes type 2	4 (4.6)
Chronic obstructive pulmonary disease	6 (7.8)
Chronic hepatitis	6 (7.8)
Neuritis of the auditory nerve	4 (4.6)
Urolithiasis disease	2 (2.3)
Obesity	2 (2.3)
Extremal active smoking	7 (8.0)

Table 2 Morphometric characteristics of palmar fascia perforating arteries in healthy control and Dupuytren’s contracture groups [Me (Q1/Q3)]

Group/parameters	Healthy control n = 3	Y-group (< 55 yr of age) n = 8	O-group (≥ 55 yr of age) n = 19
Diameter	412.8	31566 (306.96/326.91)^a^c	334.85 (309.06/441.19)^a
of artery (μm)	(351.43/506.31)	P₂ = 0.000332; P₃ = 0.136006	P₁ = 0.010485
Lumen	243.15	151.56 (94.72/153.90)^a^c	178.19 (113.78/246.52)^a
diameter (μm)	(223.07/326.52)	P₂ = 0.000736; P₃ = 0.249671	P₂ = 0.007253
Wall thickness (μm)	89.03	92.16 (80.88/106.12)^c	117.98 (98.37/133.13)^a
Wall thickness (μm)	(65.97/88.88)	P₂ = 0.49959; P₃ = 0.010846	P₂ = 0.004483
Thickness	8.41	22.26 (14.79/33.42)^a	25.37 (21.16/41.75)^a
of intima (μm)	(7.80/0.82)	P₂ = 0.004998; P₃ = 0.355126	P₂ = 0.000463
Thickness	58.45	46.52 (38.08/60.30)	46.77 (38.26/64.03)
of media (μm)	(44.01/60.28)	P₂ = 0.37436; P₃ = 0.924826	P₂ = 0.17192
Intima/media thickness ratio	0.18	0.53 (0.25/0.55)^a	0.68 (0.33/0.96)^a
Intima/media thickness ratio	(0.12/0.24)	P₂ = 0.001992; P₃ = 0.282078	P₂ = 0.000198

^aP < 0.05 vs Healthy control;

^cP < 0.05 vs O-group.

Table 3 Stereologic characteristics of hypodermis from Dupuytren’s contracture patients

Group/parameters	Y-group (< 55 yr of age) n = 15	O-group (≥ 55 yr of age) n = 14
Percentage of adipoсytes in serial sections of Dupuytren’s tissue sample [Me (Q1/Q3), %]	35.05 (23.40/40.09)^aP₁ = 0.000338	27.79 (19.37/32.82)
Numerical microvessels density [Me (Q1/Q3), μm^-2]	5 (4/7)^aP₂ = 0	3 (2/4)
Volumetric microvessels density [Me (Q1/Q3), %]	2.48 (1.44/4.13)^aP₂ = 8.88 × 10-16	1.16 (0.52/2.12)
Relative number of microvessels with signs of periadventitial inflammatory infiltration	21.84^aP₂ = 1.69 × 10-5	12.93
Relative number of microvessels with signs of adventitial fibrosis	4.48^aP₂ = 0.002358	8.19
Microvessels diameters [Me (Q1/Q3), μm]	12.55 (9.26/18.05)^aP₂ = 0.019425	11.58 (8.67/16.84)

^aP < 0.05 vs O-group.

Table 4 Parameters of microcirculatory flow and post-occlusive hyperemia test in Dupuytren’s contracture patients in younger (DCY) and older (DCO) groups and healthy controls (Norm) in different age groups [Me (Q1/Q3)]

Parameters	Norm (25-54 yr of age)n = 22	DCY (< 55 yr of age)n = 6	Norm (55-70 yr of age)n = 6	DCO (≥ 55 yr of age)n = 18
Age	33 (23/54)	52 (45/54)	59 (55/63)	66 (59/69)
Microcirculatory flow base (PU)	4 (3.5/5.7)	15.45^c (8.4/20.6) P₃ = 0.020	3.5 (2.55/4.7)	4.15^a (3.1/7.8) P₂ = 0.019
Microcirculatory flow peak (PU)	14.7 (11.8/18.3)	27.5^c (22.2/44.4) P₃ = 0.002	18.2 (8.15/18.7)	20.1 (16.7/24.6)
Microcirculatory flow peak index (%)	340 (232/443)	218.5 (125/488)	373 (223/449)	508 (336/544) P₂ = 0.045
Time of hyperemic response (s)	15 (10/25)	17.5 (10/30)	20 (20/25)	20 (15/90)
Velocity of hyperemic response (PU/s)	0.62 (0.50/0.81)	0.56 (0.14/1.19)	0.52 (0.15/0.55)	0.81 (0.21/1.09)
Time of half-recovery (s)	45 (15/75)	30 (5/60)	35 (20/70)	40 (30/130)
Speed of half-recovery (PU/s)	0.18 (0.14/0.34)	0.96 (0.16/1.54)	0.2 (0.11/0.28)	0.28 (0.09/0.49)
Time of full recovery (s)	247 (205/380)	212 (40/600)	147 (125/190)	400 (90/600)
Duration of hyperemic response (s)	270 (180/300)	242 (55/660)	165 (150/210)	515 (120/700)
Intensity (area) of hyperemic response (relative units)	1127 (705/1830)	2799 (193/6216)	1575 (474/2202)	3804 (1110/5084)

^aP < 0.05 vs DCY;

^cP < 0.05 vs corresponding norm. DCY: Dupuytren’s contracture patients in younger; DCO: Dupuytren’s contracture patients in older.

Citation: Shchudlo N, Varsegova T, Stupina T, Dolganova T, Shchudlo M, Shihaleva N, Kostin V. Assessment of palmar subcutaneous tissue vascularization in patients with Dupuytren’s contracture. World J Orthop 2018; 9(9): 130-137
URL: https://www.wjgnet.com/2218-5836/full/v9/i9/130.htm
DOI: https://dx.doi.org/10.5312/wjo.v9.i9.130